
ResistanceBio
We solve drug resistance for cancer
- Location
- San Francisco, CA, United States
- Team size
- 15 employees
- YC batch
- Winter 2019
- Status
- Shut down
- Stage
- Early stage

We solve drug resistance for cancer

What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026

What they do:
Altay develops disease-modifying therapies targeting transcription…
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$15.7M · Equity · Oct 2026

What they do:
Medicinal Chemistry powered by Machine Learning
Quick facts:
HQ: Boston, MA, United States

What they do:
Empowering women. Period.
Quick facts:
HQ: San Francisco, CA, United States

What they do:
Using the immune system to cure disease
Quick facts:
HQ: San Francisco, CA, United States

What they do:
AI Inference Platform for Drug Discovery
Quick facts:
HQ: San Francisco, CA, United States
We solve drug resistance for cancer
San Francisco, CA, United States
15 employees, according to the company profile.
There are no funding rounds for ResistanceBio in our data.
Similar startups: Numerion Labs, Altay Therapeutics, and PostEra.